We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
DMAC icon
226
DiaMedica Therapeutics
DMAC
$469M
$469M $8.69 0.23%
ALLO icon
227
Allogene Therapeutics
ALLO
$460M
$460M $1.33 0%
MPLT icon
228
MapLight Therapeutics
MPLT
$453M
$453M $8.16 0.97%
AGMB icon
229
AgomAb Therapeutics NV
AGMB
$449M
$449M $9.11 4.35%
ALT icon
230
Altimmune
ALT
$434M
$434M $2.23 3.04%
EIKN icon
231
Eikon Therapeutics
EIKN
$433M
$433M $8 2.2%
AUTL icon
232
Autolus Therapeutics
AUTL
$431M
$431M $1.62 2.41%
TECX icon
233
Tectonic Therapeutic
TECX
$427M
$427M $21.84 0.05%
INDP icon
234
Indaptus Therapeutics
INDP
$421M
$421M $3.16 6.76%
TRXB icon
235
TRex Bio, Inc. Common stock
TRXB
$418M
$418M $15.24 5.54%
ASMB icon
236
Assembly Biosciences
ASMB
$417M
$417M $20.46 3.45%
SPRY icon
237
ARS Pharmaceuticals
SPRY
$416M
$416M $4.18 2.56%
PRTA icon
238
Prothena Corp
PRTA
$412M
$412M $8.03 5.53%
YDES icon
239
YD Bio Ltd
YDES
$409M
$409M $5.77 1.2%
ZURA icon
240
Zura Bio
ZURA
$396M
$396M $4.13 3.25%
CCCC icon
241
C4 Therapeutics
CCCC
$390M
$390M $3.17 0.32%
EDIT icon
242
Editas Medicine
EDIT
$385M
$385M $2.51 2.71%
SCTX
243
Scribe Therapeutics Inc
SCTX
$365M
$365M $19.30 2.57%
FENC icon
244
Fennec Pharmaceuticals
FENC
$364M
$364M $10.38 0.76%
KYTX icon
245
Kyverna Therapeutics
KYTX
$361M
$361M $5.84 3.31%
RZLT icon
246
Rezolute
RZLT
$358M
$358M $3.70 0%
OBIO icon
247
Orchestra BioMed
OBIO
$349M
$349M $5.80 0.34%
NAUT icon
248
Nautilus Biotechnolgy
NAUT
$345M
$345M $2.71 6.27%
IRD icon
249
Opus Genetics
IRD
$343M
$343M $4.12 2.74%
RLMD icon
250
Relmada Therapeutics
RLMD
$342M
$342M $3.21 4.46%
8 9
10
11 12

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.28T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $133B, Moderna (MRNA) at $98.1B and Regeneron Pharmaceuticals (REGN) at $82.9B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.